Pharmacokinetics of Contrast Agents — MCQs

10 questions

Which of the following contrast agents is PREFERRED in a patient with renal dysfunction for the prevention of contrast-induced nephropathy?

All should be features of a substance to measure GFR, except?

A pregnant woman with head trauma requires a CT scan of the head. What is the most effective radiation protection measure for the fetus?

Contrast media of choice for a myelogram is

GFR for assessment of impaired renal function is best measured by

Which of the following statements about contrast in radiography is true:

Which contrast agent is not used for CT scans?

All of the following dyes are water soluble except:

Which of the following is a non-ionic contrast agent?

Q10

To obtain adequate diagnostic imaging in a morbidly obese patient, what modification to X-ray technique is most important?

Pharmacokinetics of Contrast Agents Indian Medical PG Practice Questions and MCQs

Question 1: Which of the following contrast agents is PREFERRED in a patient with renal dysfunction for the prevention of contrast-induced nephropathy?

A. Iso-osmolar contrast (Correct Answer)
B. High osmolar contrast
C. Ionic contrast
D. Low osmolar contrast

Explanation: ***Iso-osmolar contrast*** - **Iso-osmolar contrast agents** (e.g., iodixanol) have an osmolality of ~290 mOsm/kg, which is identical to that of plasma. - **This is the PREFERRED choice** in patients with renal dysfunction as multiple studies demonstrate the lowest risk of contrast-induced nephropathy (CIN). - The iso-osmolar formulation minimizes osmotic stress on renal tubules and reduces the risk of acute kidney injury. - **Current guidelines recommend iso-osmolar agents as first-line** in high-risk patients with pre-existing renal impairment. *Low osmolar contrast* - **Low osmolar contrast agents** have osmolality of 600-900 mOsm/kg, which is significantly lower than high osmolar agents but still 2-3 times higher than plasma. - While **acceptable and safer than high osmolar agents**, they are not as optimal as iso-osmolar contrast for patients with renal dysfunction. - These agents are widely used and represent a reasonable alternative when iso-osmolar agents are not available. *High osmolar contrast* - **High osmolar contrast agents** have osmolality >1400 mOsm/kg (about 5 times that of plasma). - They carry the **highest risk of contrast-induced nephropathy** due to severe osmotic load and direct tubular toxicity. - **Contraindicated or strongly avoided** in patients with pre-existing renal dysfunction. *Ionic contrast* - **Ionic contrast** refers to the chemical structure (dissociates into ions) rather than osmolality. - Can be either high or low osmolar—the ionic nature alone does not determine renal safety. - The critical factor for nephrotoxicity prevention is osmolality, not ionic charge.

Question 2: All should be features of a substance to measure GFR, except?

A. Freely reabsorbed (Correct Answer)
B. Not secreted by kidney
C. Freely filtered across the glomerulus membrane
D. None of the options

Explanation: ***Freely reabsorbed*** - A substance used to measure GFR should **not be reabsorbed** by the kidney tubules. If it were reabsorbed, the amount excreted in the urine would be less than the amount filtered, leading to an **underestimation of GFR**. - The ideal GFR marker is **neither reabsorbed nor secreted**, ensuring that its excretion rate directly reflects the filtration rate. *Freely filtered across the glomerulus membrane* - For a substance to accurately measure GFR, it must be **freely filtered** from the blood into the Bowman's capsule, without any restriction due to its size or charge. - This ensures that its concentration in the glomerular filtrate is the same as in the plasma, allowing for a direct calculation of the filtration rate. *Not secreted by kidney* - An ideal GFR marker should **not be secreted** by the renal tubules, as active secretion would add to the amount excreted in the urine, leading to an **overestimation of GFR**. - This property, along with not being reabsorbed, ensures that the amount of the substance appearing in the urine solely reflects the amount filtered. *None of the options* - This option is incorrect because there is a definitive feature listed among the choices that is *not* a characteristic of an ideal GFR marker. The ability to be "freely reabsorbed" is a disqualifying trait.

Question 3: A pregnant woman with head trauma requires a CT scan of the head. What is the most effective radiation protection measure for the fetus?

A. Using MRI instead
B. Lead apron over abdomen
C. Avoid CT, rely on clinical assessment
D. Reduced mA and kVp (Correct Answer)

Explanation: ***Reduced mA and kVp*** - **Optimizing scan parameters** (reducing mA and kVp) is the most effective way to minimize radiation dose during head CT in pregnancy. - Modern CT scanners with **iterative reconstruction** allow significant dose reduction without compromising diagnostic image quality. - The fetal dose from head CT is already negligible (< 0.01 mGy), but dose optimization further reduces any potential risk. - This directly addresses the radiation source rather than attempting to shield scatter radiation. *Lead apron over abdomen* - Lead shielding provides **minimal to no benefit** during head CT as the fetus is far from the primary beam. - Scatter radiation reaching the pelvis from head CT is negligible. - Lead aprons can interfere with **automatic exposure control (AEC)**, potentially increasing rather than decreasing dose. - Modern radiology guidelines (ACR, ICRP) no longer routinely recommend gonadal shielding for most CT examinations. *CT not recommended* - Withholding indicated imaging in trauma is **inappropriate and potentially dangerous**. - The diagnostic benefit of head CT in trauma far outweighs the negligible fetal risk. - **Maternal well-being** is the priority, and missing a critical head injury poses greater risk to both mother and fetus. *Using MRI instead* - While MRI has no ionizing radiation, it is **not appropriate for acute trauma** evaluation. - MRI takes longer to perform, requires patient cooperation, and is less readily available in emergency settings. - CT remains the **gold standard** for acute head trauma assessment.

Question 4: Contrast media of choice for a myelogram is

A. Urografin 75%
B. Conray 470
C. Biligrafin
D. Iohexol (Correct Answer)

Explanation: ***Iohexol*** - **Iohexol** is a **non-ionic, low osmolality contrast medium** that is widely considered the contrast agent of choice for myelography due to its safety profile. - It has a lower incidence of neurotoxicity and adverse systemic reactions compared to older ionic contrast agents, making it suitable for direct injection into the **subarachnoid space**. *Urografin 75%* - **Urografin** contains **diatrizoate meglumine and sodium**, which are **ionic contrast agents**. - While suitable for intravenous urography, **ionic contrast agents are generally contraindicated for myelography** due to a higher risk of neurotoxicity, including seizures and arachnoiditis, when injected into the cerebrospinal fluid. *Conray 470* - **Conray 470** contains **iothalamate meglumine**, another **ionic contrast medium**. - Similar to Urografin, its **high osmolality and ionic nature** make it unsuitable for intrathecal administration for myelography, as it can cause significant neurotoxic effects. *Biligrafin* - **Biligrafin** is an **ionic, high osmolality contrast medium** primarily designed for **cholangiography**, typically administered intravenously to visualize the biliary tree. - It is **not used for myelography** due to its neurotoxicity risks and formulation, which is not intended for intrathecal injection.

Question 5: GFR for assessment of impaired renal function is best measured by

A. MAG3
B. IodoHippurate
C. DTPA (Correct Answer)
D. DMSA Scan

Explanation: ***DTPA*** - **Diethylene Triamine Pentaacetic Acid (DTPA)** is the primary radiopharmaceutical used to measure **glomerular filtration rate (GFR)**, which is the gold standard for quantifying renal function. - DTPA is freely filtered by the glomeruli and not reabsorbed or secreted by the tubules, making it an excellent tracer for evaluating glomerular function and assessing the degree of renal impairment. - **Note:** While MAG3 is often preferred for dynamic renal imaging in patients with severe renal impairment (GFR < 30 ml/min) due to better image quality, DTPA remains the standard for direct GFR measurement. *MAG3* - **Mercaptoacetyltriglycine (MAG3)** is used to assess **effective renal plasma flow (ERPF)** and tubular secretion, not GFR. - MAG3 is actually preferred over DTPA for dynamic renal scintigraphy in patients with poor renal function because of its superior extraction efficiency and image quality. - However, it does not directly measure GFR, which is the primary parameter for quantifying impaired renal function. *IodoHippurate* - **IodoHippurate** (I-123 or I-131 labeled) is used to measure **effective renal plasma flow (ERPF)** through tubular secretion. - While it provides information about renal blood flow, it does not directly measure GFR and is not the primary agent for assessing the degree of renal functional impairment. *DMSA Scan* - **Dimercaptosuccinic acid (DMSA)** is used for **static cortical imaging** to assess renal parenchymal structure and detect abnormalities like renal scarring, differential renal function, or pyelonephritis. - DMSA binds to the proximal tubular cells and provides anatomical information, but does not assess dynamic renal function or measure GFR.

Question 6: Which of the following statements about contrast in radiography is true:

A. Gadolinium cannot cross an intact blood brain barrier
B. Iohexol is a high osmolar contrast media
C. Non-ionic contrast agents are always high osmolar
D. Ionic monomers have three iodine atoms per two particles in solution (Correct Answer)

Explanation: ***Ionic monomers have three iodine atoms per two particles in solution*** - **Ionic monomeric contrast agents** (e.g., diatrizoate, iothalamate) dissociate in solution, producing **two particles** (one cation and one anion containing three iodine atoms) per molecule. - This dissociation results in a **high osmolality** compared to non-ionic agents, as osmolality is determined by the number of particles in solution. *Gadolinium cannot cross an intact blood brain barrier* - This statement is **FALSE** - **Gadolinium-based contrast agents CAN cross the blood-brain barrier when it is compromised**. - They are used in MRI precisely because they extravasate into tissues where the **blood-brain barrier is disrupted**, such as in tumors, inflammation, or infections. - However, they do **not cross an intact BBB** due to their size and hydrophilicity. *Iohexol is a high osmolar contrast media* - **Iohexol** is a **non-ionic, low osmolality contrast medium** (LOCM). - Its non-ionic nature means it does not dissociate in solution, leading to a significantly lower osmolality compared to older ionic agents. *Non-ionic contrast agents are always high osmolar* - **Non-ionic contrast agents** are characterized by their molecular structure which **does not dissociate into ions** in solution. - This property makes them **low osmolar** or **iso-osmolar**, meaning they have fewer particles in solution compared to ionic agents, thereby reducing osmolality.

Question 7: Which contrast agent is not used for CT scans?

A. CO2 (Correct Answer)
B. Iodinated high-osmolality contrast media
C. Barium compounds
D. Gadolinium-based contrast agents

Explanation: ***CO2*** - **CO2** (carbon dioxide) is **not used as a contrast agent in CT scans**. - CO2 is primarily used in **angiography** (especially for peripheral vessels in patients with iodine allergy or renal insufficiency) where it acts as a negative contrast agent. - In CT, CO2 would appear as air/gas density and create artifacts rather than providing diagnostic enhancement, making it unsuitable for routine CT imaging. *Iodinated high-osmolality contrast media* - These are **iodinated contrast agents** that contain iodine atoms which strongly attenuate X-rays, making them highly effective for **CT imaging**. - High-osmolality contrast media (HOCM) like **diatrizoate** and **iothalamate** were the standard CT contrast agents historically. - They have largely been replaced by **low-osmolality** and **iso-osmolality** agents due to higher incidence of **adverse reactions**, but they are still used for CT scans. *Barium compounds* - **Barium sulfate** suspensions are widely used as **oral or rectal contrast agents** for CT imaging of the gastrointestinal tract. - Barium has high atomic number and effectively attenuates X-rays, making the **GI lumen clearly visible** on CT scans. - Used in **CT enterography**, **CT colonography**, and routine **abdominal/pelvic CT** protocols. *Gadolinium-based contrast agents* - **Gadolinium-based contrast agents (GBCAs)** are primarily designed for **MRI** due to their **paramagnetic properties**. - However, gadolinium DOES attenuate X-rays and can be used **off-label for CT** in patients with **severe iodine allergy** or **contraindications to iodinated contrast**. - While less effective than iodinated agents for CT (requiring higher doses), gadolinium-enhanced CT is a recognized alternative in special clinical circumstances.

Question 8: All of the following dyes are water soluble except:

A. Myodil (Correct Answer)
B. Iohexol
C. Conray 420
D. Metrizamide

Explanation: ***Myodil*** - **Myodil** (Iophendylate) is an **oil-based** contrast medium previously used for myelography. - Due to its **oil-based nature**, it is not water-soluble and had to be removed after the procedure to prevent complications. *Iohexol* - **Iohexol** is a **non-ionic, water-soluble** contrast agent commonly used in various radiological procedures, including myelography. - Its water solubility allows for easy absorption and excretion from the body. *Conray 420* - **Conray 420** (Iothalamate meglumine) is an **ionic, water-soluble** contrast agent often used for angiography and urography. - It readily mixes with bodily fluids due to its water-soluble properties. *Metrizamide* - **Metrizamide** was an early **non-ionic, water-soluble** contrast agent specifically developed for myelography. - Although water-soluble, it had a higher incidence of neurotoxicity compared to newer agents like iohexol.

Question 9: Which of the following is a non-ionic contrast agent?

A. Amidotrizoate
B. Iothalamate
C. Ioxoglate
D. Iohexol (Correct Answer)

Explanation: ***Iohexol*** - **Iohexol** is a well-known example of a **non-ionic, low osmolar contrast agent**. It's widely used due to its lower incidence of adverse reactions compared to ionic agents. - Non-ionic contrast agents remain as **intact molecules** in solution and do not dissociate into charged ions, contributing to their lower osmolality and better tolerability. *Amidotrizoate* - **Amidotrizoate** (also known as diatrizoate) is an **ionic, high osmolar contrast agent**. It dissociates into two ions in solution. - Due to its high osmolality, it is associated with a higher risk of adverse effects, such as **nausea**, **vomiting**, and **nephrotoxicity**. *Iothalamate* - **Iothalamate** is another example of an **ionic, high osmolar contrast agent**. It also dissociates into charged ions when dissolved. - Its use has decreased significantly with the development of safer non-ionic alternatives due to its higher potential for **adverse drug reactions**. *Ioxoglate* - **Ioxoglate** is a **dimeric, ionic contrast agent**. Although it's ionic, it has a lower osmolality than monomeric ionic agents due to its dimeric structure. - Despite being dimeric, it still dissociates into ions, distinguishing it from truly non-ionic compounds like iohexol.

Question 10: To obtain adequate diagnostic imaging in a morbidly obese patient, what modification to X-ray technique is most important?

A. Increase MAS
B. Decrease KVP
C. Increase KVP (Correct Answer)
D. Decrease MAS

Explanation: ***Increase KVP*** - Increasing the **kilovoltage peak (KVP)** is essential for imaging morbidly obese patients because it increases the **penetrating power** of the X-ray beam, allowing adequate transmission through thick body tissues. - Higher KVP (typically 90-120 kVp range) ensures the X-ray beam can penetrate increased soft tissue thickness and reach the image receptor with sufficient intensity. - While higher KVP produces **longer scale (lower) contrast**, it is necessary for adequate **penetration** in obese patients - without sufficient KVP, the image would be underexposed and non-diagnostic. - In practice, both KVP and MAS are increased for obese patients, but **KVP increase is more critical** for penetration. *Increase MAS* - Increasing **milliampere-seconds (MAS)** increases the quantity of X-ray photons and image density (brightness), which is also helpful for obese patients. - However, MAS alone without adequate KVP cannot solve the penetration problem - the photons would still be too low energy to penetrate thick tissues effectively. - MAS increase without KVP increase would result in high patient dose with poor image quality. *Decrease KVP* - Decreasing KVP reduces **beam penetration**, which would be catastrophic for imaging an obese patient. - The X-ray beam would be absorbed by superficial tissues, resulting in a severely **underexposed** and non-diagnostic image. - While lower KVP produces higher contrast in theory, it is completely inappropriate for thick body parts. *Decrease MAS* - Decreasing MAS reduces the number of X-ray photons, resulting in an **underexposed, lighter** image. - This would make it even more difficult to obtain adequate imaging through increased body mass, resulting in a non-diagnostic radiograph with excessive quantum mottle.

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free